Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 3 studies | 23% ± 9% | |
GABAergic neuron | 3 studies | 24% ± 5% | |
glutamatergic neuron | 3 studies | 35% ± 8% | |
astrocyte | 3 studies | 19% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 22% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2956.98 | 1445 / 1445 | 100% | 15.92 | 183 / 183 |
intestine | 100% | 3204.21 | 966 / 966 | 100% | 7.99 | 526 / 527 |
prostate | 100% | 3862.04 | 245 / 245 | 100% | 9.07 | 501 / 502 |
skin | 100% | 3631.19 | 1809 / 1809 | 100% | 10.89 | 471 / 472 |
thymus | 100% | 4429.85 | 653 / 653 | 100% | 11.55 | 603 / 605 |
breast | 100% | 2802.69 | 459 / 459 | 100% | 10.80 | 1114 / 1118 |
uterus | 100% | 3146.86 | 170 / 170 | 100% | 10.54 | 457 / 459 |
brain | 100% | 3000.57 | 2631 / 2642 | 100% | 13.50 | 704 / 705 |
lung | 100% | 2927.02 | 578 / 578 | 99% | 9.57 | 1142 / 1155 |
pancreas | 99% | 1603.92 | 326 / 328 | 99% | 8.16 | 177 / 178 |
bladder | 100% | 3202.71 | 21 / 21 | 99% | 8.87 | 498 / 504 |
stomach | 100% | 2286.64 | 359 / 359 | 99% | 8.79 | 282 / 286 |
kidney | 100% | 2786.84 | 89 / 89 | 98% | 8.16 | 881 / 901 |
adrenal gland | 100% | 2686.22 | 258 / 258 | 97% | 8.80 | 223 / 230 |
ovary | 100% | 3116.76 | 180 / 180 | 96% | 9.43 | 414 / 430 |
liver | 99% | 1301.42 | 224 / 226 | 96% | 5.97 | 390 / 406 |
adipose | 100% | 2320.65 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 11.53 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 14.97 | 29 / 29 |
spleen | 100% | 4671.78 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 16.74 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.09 | 1 / 1 |
blood vessel | 100% | 2211.00 | 1332 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 2046.89 | 896 / 929 | 0% | 0 | 0 / 0 |
muscle | 96% | 1036.73 | 773 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 1250.62 | 826 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0000226 | Biological process | microtubule cytoskeleton organization |
GO_0007088 | Biological process | regulation of mitotic nuclear division |
GO_0005829 | Cellular component | cytosol |
GO_0031461 | Cellular component | cullin-RING ubiquitin ligase complex |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | CUL9 |
Protein name | CUL9 protein RBR-type E3 ubiquitin transferase (EC 2.3.2.31) Alternative protein CUL9 Cullin 9 Cullin-9 (CUL-9) (UbcH7-associated protein 1) (p53-associated parkin-like cytoplasmic protein) |
Synonyms | KIAA0708 H7AP1 PARC |
Description | FUNCTION: Core component of a Cul9-RING ubiquitin-protein ligase complex, a complex that mediates ubiquitination and subsequent degradation of BIRC5 and is required to maintain microtubule dynamics and genome integrity. Acts downstream of the 3M complex, which inhibits CUL9 activity, leading to prevent ubiquitination of BIRC5 . Cytoplasmic anchor protein in p53/TP53-associated protein complex. Regulates the subcellular localization of p53/TP53 and subsequent function . . |
Accessions | Q05C85 E9PEZ1 ENST00000372647.6 L8E9R8 H0YA00 ENST00000506830.5 ENST00000502719.5 Q8IWT3 H0Y8H9 ENST00000252050.9 [Q8IWT3-1] |